|
|
|
Office:
|
New York, NY
|
Email:
|
bailey@trilliummed.com
|
Mobile Phone:
|
(646) 478 - 6951
|
Office Phone:
|
(212) 620 - 5880 ext. 1
|
|
STEVEN C. BAILEY, Ph.D. GENERAL PARTNER
Steven C. Bailey, has a Ph.D. in pharmacology and 18 years of experience in academic medical
research, the pharmaceutical industry at major drug companies (Hoechst and Schering AG), and venture
investing. Dr. Bailey has held research positions in oncology, hematology, and dermatology with
responsibility for selecting drug targets and advancing drug candidates though pre-clinical development
and toxicological profiling. Dr. Bailey was also responsible for the compilation and filing of four
successful New Drug Applications. Dr. Bailey has also helped manage the investments of Schering Berlin
Venture Corporation, a venture capital fund investing in health care sector, where he was responsible
for identification and due diligence analysis of investment opportunities. Dr. Bailey was a co-founder
of Trillium Medical Ventures, LLC in November of 1998. Dr. Bailey received a B.Sc. degree in biology
at Cornell University, a Ph.D. in Pharmacology from the Mount Sinai Medical School in New York
and fellowship training in hematology/oncology at the Harvard Medical School.
|
|